mesothelioma

In a pan-cancer analysis, Lynch syndrome genes were mutated more often than anticipated in tumors with high or intermediate levels of microsatellite instability.

Researchers identified unique ALK rearrangements in patients that lack previously known indicators of mesothelioma.

This Week in PNAS

In PNAS this week: recurrent deletions in mesothelioma patients, mutagenesis screen for genes working with PTEN in triple-negative breast cancer, and more.

This Week in Nature

In Nature this week: genome-wide association study links genetic variants to a number of hair traits, and more.

Genomic and transcriptomic sequence data from hundreds of mesothelioma tumors has uncovered recurrent gene mutations, gene fusions, and pathway alterations.

Survey results reflect strong penetration of Castle Biosciences' uveal melanoma test among specialists as the company plans a future focus on more prevalent diseases.

NEW YORK (GenomeWeb) – Australia's Asbestos Diseases Research Institute (ADRI) has recently begun enrolling patients in a Phase I trial of a microRNA-based treatment for malignant pleural mesothelioma (MPM), marking the second time a drug based on the small, non-coding RNAs has moved into human t

NEW YORK (GenomeWeb) – Cancer molecular diagnostics firm Castle Biosciences today said that it raised $11.8 million in a Series E financing round.

Proteomics diagnostics firm Somalogic reported data this week supporting the utility of its blood-based 13-protein panel for the detection of malignant mesothelioma.

NEW YORK (GenomeWeb News) – Castle Biosciences has licensed the IP and technology rights from Brigham and Women's Hospital for a gene expression profiling test for mesothelioma, the company announced today.

Pages

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.